- Home
- INSM vs FE Comparison
INSM vs FE Comparison
Compare INSM & FE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INSM | FE |
|---|---|---|
| Founded | 1988 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.1B | 29.6B |
| IPO Year | 2000 | 2005 |
Fundamental Metrics
Financial Performance| Metric | INSM | FE |
|---|---|---|
| Price | $162.30 | $51.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 24 | 15 |
| Target Price | ★ $200.48 | $49.71 |
| AVG Volume (30 Days) | 2.1M | ★ 3.7M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.49% |
| EPS Growth | N/A | ★ 3.53 |
| EPS | N/A | ★ 1.76 |
| Revenue | N/A | ★ $15,090,000,000.00 |
| Revenue This Year | $174.73 | $2.90 |
| Revenue Next Year | $65.13 | $3.73 |
| P/E Ratio | ★ N/A | $28.95 |
| Revenue Growth | N/A | ★ 12.01 |
| 52 Week Low | $60.40 | $37.58 |
| 52 Week High | $212.75 | $52.29 |
Technical Indicators
Market Signals| Indicator | INSM | FE |
|---|---|---|
| Relative Strength Index (RSI) | 60.93 | 61.73 |
| Support Level | $157.91 | $49.74 |
| Resistance Level | $167.01 | $51.70 |
| Average True Range (ATR) | 6.19 | 1.03 |
| MACD | 3.01 | 0.03 |
| Stochastic Oscillator | 84.92 | 74.94 |
Price Performance
Historical ComparisonAbout INSM Insmed Incorporated
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.
About FE FirstEnergy Corp.
FirstEnergy is an investor-owned holding company with operations across five mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems.